← Leaderboards
Mark S Kindy
University Of Kentucky
$3,948,188
Attributed
$4,153,750
Total exposure
14
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $624.6K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,153,750 · 8
VA$0 · 6
By mechanism
R01$2,954,716 · 4
P20$433,619 · 2
R21$411,125 · 1
T32$354,290 · 1
IS1$0 · 2
I01$0 · 3
Top collaborators
- Kelley M Argraves3 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- L. Creed Pettigrew$1,223,155
- William R Markesbery$12,693,618
- Guangxiang George Luo$12,758,769
Others in their field
Top investigators on “Animals”
- David Heimbrook · Leidos Biomedical Research, Inc.$534,904,829
- Richard Webby · St. Jude Children'S Research Hospital$259,408,394
- Eric S Lander · Whitehead Institute For Biomedical Res$209,574,154
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Richard K. Wilson · Washington University$130,501,539
- Mark S Klempner · Tufts Medical Center$129,182,794
Research focus
AnimalsProductionGenerationsBrainAlzheimer&AposPathogenesisTraumatic Brain InjuryInjuryTissuesStrokeIn VivoReceptorMediatingInflammationNeuronsSpinal Cord InjuryCerebral IschemiaPharmacologic SubstanceAntibodiesPlayInflammatoryNeuron LossRattusNeurologic
Grant awards (37)
Role of Serum Amyloid A in the Pathogenesis of Stroke$0
I01 · FY2025 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2024 · VA · contact PI
Role of Serum Amyloid A in the Pathogenesis of Stroke$0
I01 · FY2024 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2023 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2022 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2021 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2020 · VA · contact PI
Targeted Delivery of Antioxidant Drugs Following Cerebral Ischemic Injury$0
I01 · FY2019 · VA · contact PI
ShEEP Request for 4D Bioprinting-Biofabrication of stimuli-responsive materials$0
IS1 · FY2019 · VA · contact PI
ShEEP Request for CLARITY Optimized Light sheet Microscope for high speed imaging of large clarified samples at high resolution$0
IS1 · FY2017 · VA · contact PI
Targeted Delivery of Antioxidant Drugs Following Cerebral Ischemic Injury$0
I01 · FY2017 · VA · contact PI
Targeted Delivery of Antioxidant Drugs Following Cerebral Ischemic Injury$0
I01 · FY2017 · VA · contact PI
Targeted Delivery of Antioxidant Drugs Following Cerebral Ischemic Injury$0
I01 · FY2016 · VA · contact PI
Targeted Delivery of Antioxidant Drugs Following Cerebral Ischemic Injury$0
I01 · FY2016 · VA · contact PI
Targeted Delivery of Antioxidant Drugs Following Cerebral Ischemic Injury$0
I01 · FY2015 · VA · contact PI
Role of Fibulin-1 in APP Processing$146,875
R21 · FY2014 · AG · contact PI
Role of Fibulin-1 in APP Processing$40,000
R21 · FY2014 · AG · contact PI
Complement and Traumatic Brain Injury$0
I01 · FY2014 · VA · contact PI
Complement and Traumatic Brain Injury$0
I01 · FY2014 · VA · contact PI
Complement and Traumatic Brain Injury$0
I01 · FY2014 · VA · contact PI
Role of Fibulin-1 in APP Processing$224,250
R21 · FY2013 · AG · contact PI
Complement and Traumatic Brain Injury$0
I01 · FY2012 · VA · contact PI
Pesticides, Paraoxonase and Alzheimer's Disease$405,625
R01 · FY2010 · ES · contact PI
Pesticides, Paraoxonase and Alzheimer's Disease$405,625
R01 · FY2009 · ES · contact PI
SC COBRE: ANIMAL PATHOBIOLOGY CORE$218,998
P20 · FY2009 · RR · contact PI
SC COBRE: ANIMAL PATHOBIOLOGY CORE$214,621
P20 · FY2008 · RR · contact PI
Neprilysin and Abeta-degradation in Alzheimer's disease$225,560
R01 · FY2005 · AG
Oxidized Lipoproteins in Neurodegeneration$292,000
R01 · FY2004 · NS
Neprilysin and Abeta-degradation in Alzheimer's disease$225,560
R01 · FY2004 · AG
Oxidized Lipoproteins in Neurodegeneration$292,000
R01 · FY2003 · NS
Neprilysin and Abeta-degradation in Alzheimer's disease$237,060
R01 · FY2003 · AG
MELATONIN- A NEW ANTI-AMYLOIDOGENIC &ANTIOXIDANT AGENT$22,758
R01 · FY2003 · AG
Oxidized Lipoproteins in Neurodegeneration$289,600
R01 · FY2002 · NS
Neprilysin and Abeta-degradation in Alzheimer's disease$269,328
R01 · FY2002 · AG
THE MOLECULAR AND CELLULAR BASIS OF BRAIN AGING$354,290
T32 · FY2001 · AG
Oxidized Lipoproteins in Neurodegeneration$289,600
R01 · FY2001 · NS